Patent Yard Sign in
Canadian application, no grantCanada

Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia

CA 2383783 A1 · Owner: Schaefer, Hans-Ludwig · Inventors: Schaefer, Hans-Ludwig; Kirsch, Reinhard; Falk, Eugen

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention relates to the use of bis-sulfonamides and of their , physiologically compatible salts and physiologically functional derivatives for producing medicaments used for preventing or treating hyperlipidaemia. The invention involves the use of compounds of formula (I) wherein the radicals , have the cited meanings and the use of their physiologically compatible salts and physiologically functional derivatives for producing a medicament used for preventing or treating hyperlipidaemia or arteriosclerosis.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 17, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 17, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 17, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 17, 2000
GrantedNo grant recorded
Term endedAugust 17, 2020
Patent numberCA 2383783 A1
Classification (IPC)A61K31/63 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedAug 17, 2000Term endedAug 17, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.